RxDoctor Payments Data

John Findley, MD

Psychiatry · Boston, MANPI 1891777504

Payments from drug & device makers

$642in general payments, 2019–2025

Across 26 payments — averaging $24.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$125
  • Johnson & Johnson$112
  • AbbVie$84
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$67
  • Alkermes, Inc.$64
  • E.r. Squibb & Sons, L.L.C.$55
  • plus $135 from 4 others

What the payments were for

  • Food & beverage$642100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$642 in reported general payments places this provider in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$127,017
Medicare patients
200
Services billed
2,594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$11,901
LinzessLinaclotide15$8,040
Albuterol Sulfate HfaAlbuterol Sulfate29$851
Risperidone36$790
FenofibrateFenofibrate Nanocrystallized11$747
Haloperidol16$501
Quetiapine Fumarate47$493
Omeprazole37$465
Olanzapine23$392
Mirtazapine34$390
Gabapentin26$351
Atorvastatin Calcium52$345
Trazodone Hcl48$267
Benztropine Mesylate24$253
Alendronate Sodium15$250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$84$8,04015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →